Caitlin Raymond: Understanding Risks in Rare Group A Subtypes with Anti-A1 Antibodies in Transfusion Medicine
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared a post on LinkedIn:
”In transfusion medicine, some risks feel larger than they actually are — not because they’re common, but because the evidence we have is skewed toward worst-case scenarios.
I recently wrote a follow-up blog post on rare group A subtypes with anti-A1 antibodies, prompted by a real case and a conversation with a reference laboratory.
Case reports tell us what can go wrong. Reference labs see what actually does go wrong — and how often.
This post walks through:
- When cold reacting anti-A1 actually becomes dangerous
- Why malignancy-associated cases don’t generalize
- When to choose group O blood for rare group A subtypes
If you’ve ever felt uneasy making decisions where the literature offers warnings but no denominator, this one’s for you.”
Stay updated with Hemostasis Today.
-
Feb 7, 2026, 14:57Akinchan Bhardwaj։ OCEANIC-STROKE Trial Signals a New Era in Secondary Stroke Prevention
-
Feb 7, 2026, 14:32Ming Y Lim: Launching a Virtual Iron Deficiency Clinic at the University of Utah School of Medicine
-
Feb 7, 2026, 14:30Exploring Thrombin Generation Profiling in Rare Coagulation Factor Deficiencies – JTH
-
Feb 7, 2026, 14:25C Michael Gibson: Asundexian Reduces Ischemic Stroke Without Increasing Bleeding Risk
-
Feb 7, 2026, 14:23Marco Antonio Ramírez Rodríguez: Endovascular Management of Pelvic Venous Hypertension in May–Thurner Syndrome
-
Feb 7, 2026, 14:19Martin Haluzík Analyzes the Overall Accuracy of Current Available Smartwatches in Identifying AF
-
Feb 7, 2026, 14:11Bhupesh Prusty: How Patient-Derived IgG Immune Complexes Directly Affect Human Cells
-
Feb 7, 2026, 14:05Samary Vazquez: Insights from My Hospital Bed – Guilt and Survival
-
Feb 7, 2026, 13:59Michael Ertl: Discussing Cerebral Vasospasm and Ultrasound Training at ANIM 2026